Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: A multicentre, retrospective UK study

Journal of Cosmetic Dermatology

Volumn 5, Issue 3, 2006, Pages 218-226

  Palmer, Mark ^a   Curran, John ^a   Bowler, Patrick ^a  

^a British Association of Cosmetic Doctors   (United Kingdom)

Author keywords

Adverse effects; Phosphatidylcholine; Subcutaneous fat

Indexed keywords

PHOSPHATIDYLCHOLINE;

ADULT; ARTICLE; BREAKTHROUGH BLEEDING; BURN; CLINICAL ARTICLE; CLINICAL PRACTICE; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG SURVEILLANCE PROGRAM; ERYTHEMA; FEMALE; HUMAN; INCIDENCE; LIPOLYSIS; MALE; NAUSEA; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SAFETY; SKIN BRUISING; SUBCUTANEOUS FAT; SWELLING; TIME SERIES ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; COSMETIC TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOSPHATIDYLCHOLINES; RETROSPECTIVE STUDIES; SUBCUTANEOUS FAT; TREATMENT OUTCOME;

EID: 33748152015     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2006.00257.x     Document Type: Article

References (41)

1. Kidd PM. Phosphatidylcholine, a superior protectant against liver damage. Altern Med Rev 1996; 1: 258-74.
2. Guranda AI, Vladyka AS, Golynskii GIU et al. Experience of anesthesiology and intensive care services in mass admission of victims with fight injuries. Anesteziol Reanimatol 1994; 1: 44-7.
3. Kroupa J. The role of pharmacology in the comprehensive prophylaxis of post-traumatic fat embolism. Acta Chir Orthop Traumatol Cech 1993; 60: 114-22.
4. Kroupa J, Uher J, Utrata F. Lipostabil in the prevention of fat embolism. Z Exp Chir 1972; 5: 379-92.
5. Kroupa J. Lipostabil in the prevention of fat embolism. Rozhl Chir 1966 July; 45: 444-52.
6. Bruha R, Marecek Z. Essential phospholipids in the treatment of hepatic encephalopathy. Vnitrni Lekarstvi 2000; 46: 199-204.
7. Niederau C, Strohmeyer G, Heintges T et al. Polyunsaturated phosphatidylcholine and interferon alpha for treatment of chronic hepatitis H and C: A multicenter, double-blind, placebo-controlled trial. Hepatogastroenterology 1998; 45: 797-804.
8. Kidd PM. Dietary phospholipids as anti-aging nutraceuticals. In: RA Klatz, R Goldman, eds. Anti-Aging Medical Therapeutics. Chicago: Health Quest Publications; 2000: Pp. 283-301.
9. Kidd PM. Cell membranes, endothelia, and atherosclerosis -the importance of dietary fatty acid balance. Altern Med Rev 1996; 1: 148-67.
10. http://www.network-Iipolysis.com
11. Duncan DI, Hasengschwandtner F. Lipodissolve for subcutaneous fat reduction and skin retraction. Aesthetic Surg J 2005; 25: 530-43.
12. Hasengschwandtner F. Die subcutane Injektion von Phosphatidylcholin (Lipostabil N®) zum Zwecke der Lipolyse (The subcutaneous injection of phosphatidylcholine for means of lipolysis). Aktuelle Dermatologie 2005; 31: 549.
13. Hexsel D, Serra M, Mazzuco R et al. Cosmetic Uses of Injectable Phosphatidylcholine on the Face. Otolaryngologic Clinics of North America 2005; 38: 1119-29.
14. Hasengschwandtner F. Phosphatidylcholine treatment to induce lipolysis. J Cosmet Dermatol 2005; 4: 308.
15. Rose PT, Morgan M. Histological changes associated with mesotherapy for fat dissolution. J Cosmet Laser Ther 2005; 7: 17-9.
16. Ablon G, Rotunda AM. Treatment of lower eyelid fat pads using phosphatidylcholine: Clinical trial and review. Dermatol Surg 2004; 30: 422-8.
17. Worcester S. Phosphatidylcholine Improved Fat Pad Herniation. Skin Allergy News 2003; 34: 34.
18. Young VL. Lipostabil: The effect of phosphatidylcholine on subcutaneous fat. Aesthetic Surg J 2003; 23: 413-7.
19. Rittes PG. The use of phosphatidylcholine for correction of localized fat deposits. Aesthetic Plast Surg 2003; 27: 315-8.
20. Baumann LS. Phosphatidylcholine. Skin Allergy News 2003; 34: 24.
21. Donohue M. Lecithin Injection Reduces Lower Eyelid Fat Pads. Skin Allergy News 2001; 32: 23.
22. Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001; 27: 391-2.
23. Peckitt N. Evidenced Based Practice: Phosphatidylcholine. A Review of Evidence for the Mode of Action in Injection Lipolysis. Huddersfield, UK: Jeremy Mills Publishing; 2006.
24. Parnham MJ, Wendel A. Phospholipids and liposomes-safety for cosmetic and pharmaceutical use. Natterman Phospholipid GMBH Scientific Publication #1995432003, 2. Cologne, West Germany: Natterman International GMBH; 1990.
25. Bobkova VI, Lokshina LI, Korsunskii VN et al. Metabolic effect of lipostabil-forte. Kardiologiia 1989; 29: 57-60.
26. Rotunda AM, Suzuki H, Moy RL et al. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004; 30: 1001-8.
27. Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 2005; 53: 973-8.
28. Peckitt N. The molecular biology of adipocyte differentiation and apoptosis. Presented at the 1st International Convention for Lipodissolve, June 18-19 2005, Salzburg, Austria.
29. Mathur S, Born E, Murthy S et al. Phosphatidylcholine increases the secretion of triacylglycerol-rich lipoproteins by CaCo-2 cells. Biochem J 1996; 14: 569-75.
30. Suresh GK, Soll RF. Overview of surfactant replacement trials. J Perinatol 2005; 25 (Suppl. 2): S40-4.
31. Zimmermann LJ, Janssen DJ, Tibboel D et al. Surfactant metabolism in the neonate. Biology of the Neonate 2005; 87: 296-307. Epub 2005 June 1.
32. Meissner C. Complications with Injection Lipolysis. 1st International Congress Network-Lipolysis, Frankfurt, Germany, 13 November 2004; 1st International Convention for Lipodissolve, 18-19 June 2005, Salzburg, Austria; 2nd International Congress Network-Lipolysis, 26 November 2005, Paris, France.
33. Hexsel D, Serra M, Mazzuco R et al. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol 2003; 2: 511-8.
34. Hasengschwandtner F. Lipolysis Injection with Phosphatidylcholine (Lipostabil N ®). Examination of blood values after subcutaneous administration. The examination of γGT (gamma glutamyl transferase) and bilirubin in 46 experimentees following lipodissolve injection. [WWW document] URL http://www.doc1.at
35. Almazov VA, Freidlin IS, Krasil'nikova EI. Use of lipostabil to correct lipid metabolism disorder with ischemic heart disease. Kardiologiia 1986; 26: 39-42.
36. Melchinskaya EN, Gromnatasky NI, Kirichenko LL. Hypolipidemic effects of Alisat and Lipostabil in patients with diabetes mellitus. Ter Arkh 2000; 72: 57-8.
37. Lijnen P, Echevaria-Vazquez D, Petrov V. Influence of cholesterol-lowering on plasma membrane lipids and function. Meth Find Exp Clin Pharmacol 1996; 18: 123-36.
38. Grazer FM, de Jong RH. Fatal outcomes from liposuction: Census survey of cosmetic surgeons. Plastic and Reconstructive Surgery 2000; 105: 436-48.
39. Daane SP, Rockwell WB. Analysis of methods for reporting severe and mortal lipoplasty complications. Aesthetic Plastic Surg 1999; 23: 303-6.
40. Platt MS, Kohler LJ, Ruiz R et al. Deaths associated with liposuction: case reports and review of the literature. J Forensic Sci 2002; 47: 205-7.
41. Lehnhardt M, Homann HH, Druecke D et al. No problem with liposuction? Chirurg 2003; 74: 808-14.